ysm growth: a meta-analysis and meta-regression of
observational comparative studies. Eur J Vasc Endovasc
Surg 2012;44:287-92.
289. Wemmelund H, Hogh A, Hundborg HH, Thomsen RW,
Johnsen SP, Lindholt JS. Statin use and rupture of
abdominal aortic aneurysm. Br J Surg 2014;101:966-75.
290. Periard D, Guessous I, Mazzolai L, Haesler E, Monney P,
Hayoz D. Reduction of small infrarenal abdominal aortic
aneurysm expansion rate by statins. Vasa 2012;41:35-42.
291. Sweeting MJ, Thompson SG, Brown LC, Greenhalgh RM,
Powell JT. Use of angiotensin converting enzyme inhibitors
is associated with increased growth rate of abdominal
aortic aneurysms. J Vasc Surg 2010;52:1-4.
292. Kristensen KE, Torp-Pedersen C, Gislason GH, Egfjord M,
Rasmussen HB, Hansen PR. Angiotensin-converting
enzyme inhibitors and angiotensin II receptor blockers in
patients with abdominal aortic aneurysms: nation-wide
cohort study. Arterioscler Thromb Vasc Biol 2015;35:
733-40.
293. Lederle FA, Taylor BC. ACE inhibitors and aortic rupture.
Lancet 2006;368:1571.
294. Lindholt JS, Ashton HA, Scott RA. Indicators of infection
with Chlamydia pneumoniae are associated with expansion of abdominal aortic aneurysms. J Vasc Surg 2001;34:
212-5.
295. Karlsson L, Gnarpe J, Bergqvist D, Lindback J, Parsson H. The
effect of azithromycin and Chlamydophilia pneumonia
infection on expansion of small abdominal aortic
aneurysmsda prospective randomized double-blind